BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

New Medium and Feeds System from Thermo Fisher Scientific Boosts CHO Cell Culture Performance

Thermo Fisher Scientific, a leading biotechnology company, recently provided expert insights into its new media and feed system, Gibco™ Effic...

March 21, 2023 | News

BioNTech and OncoC4 to Co-Develop and Commercialize Novel Checkpoint Antibody for Solid Tumor Treatment

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”), a clinical-stage biopharmaceutical company dedicated...

March 20, 2023 | News

Etana has secured financing from Deg, East Ventures and other global investors

Etana is committed to build production capacity for mammalian cell for monoclonal antibodies drug substance to ensure high local content production a...

March 20, 2023 | News

Keymed Biosciences Advancing Clinical Progress and Global Collaboration

Development of Innovative and Differentiated Pipelines Core Product CM310 (IL-4Rα antibody): Initiated Phase III registrational cl...

March 18, 2023 | News

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Ill...

March 15, 2023 | News

AnnJi Pharma and Avenue Therapeutics Enter Licensing Agreement for Clinical Asset AJ201 to Treat Kennedy's Disease.

Under the terms of the license agreement, AnnJi will receive upfront payments of $3 million and is entitled to receive future development, regula...

March 13, 2023 | News

Allorion Therapeutics Raises $50M in Series B Financing for Precision Medicine in Oncology and Autoimmune Diseases

The funds raised in this round will primarily support upcoming Phase I/II clinical trials in both China and the U.S. and the identification of cl...

March 11, 2023 | News

Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches

-- Integrated offering to be highlighted at Festival of Biologics -- -- Tracey Mullen, MBA, to lead Twist Biopharma Solutions - The offering...

March 10, 2023 | News

Allorion Therapeutics raises $50M for precision medicine in oncology and autoimmune diseases

The funds raised in this round will primarily support upcoming Phase I/II clinical trials in both China and the U.S. and the identification of cl...

March 10, 2023 | News

Alnylam and Medison Pharma expand RNAi Therapeutics Partnership

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma co...

March 09, 2023 | News

Estrella Biopharma's ARTEMIS® T Cell Therapy EB103 IND Cleared by FDA for B-Cell Lymphomas Clinical Trial

Estrella Biopharma, Inc. ("Estrella"), a biopharmaceutical company whose mission is to harness the evolutionary power of the human immune system to transfo...

March 09, 2023 | News

Mallinckrodt's CELLEX® ECP System Reimbursed in Japan for cGvHD Treatment

– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD &nd...

March 09, 2023 | News

MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules

“We are thrilled to offer this cutting-edge technology to the research community,” says Jos Joore, co-CEO of MIMETAS. “We&rsquo...

March 08, 2023 | News

Abacus Medicine Pharma Services and AddMedica Sign Partnership Agreement for the Distribution of Siklos® in Benelux

Simon Estcourt, Managing Director of Abacus Medicine Pharma Services explains: “This partnership agreement between Abacus Medicine Pharma Servic...

March 07, 2023 | News

Stay Connected